Scotland Fast Tracks HTA For AbbVie’s Aquipta While England Switches To Lengthier Process
Executive Summary
Scotland’s health technology assessment body has beaten its counterpart in England to approving AbbVie’s migraine treatment Aquipta for reimbursement on the National Health System.